Youngsoo Kim
Ionis Pharmaceuticals (United States)
ORCID: 0000-0002-7592-1387Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 3 papers. Top paper: “Selective antisense oligonucleotide inhibition of human IRF4 prevents malignant myeloma regeneration via cell cycle disruption”.
Ashni A. Vora, Tianyuan Zhou, Elisa Lazzari, Luisa Ladel, Xiaolin Luo +6 more
Jun-Young Lee, Jee Hee Seo, Hwa Young Lee, Shi Yong Ryu, Byung Woo Ahn +5 more
Sydney L. Olson, John C. S. Harding, Hemalatha Sundaramoorthi, Youngsoo Kim, Tianyuan Zhou +4 more